Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Lung Cancer Chemoprevention
NCT04931017Phase 2Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Sep 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in lung carcinoma, sponsored by Northwestern University. Started Sep 2022; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
lung carcinoma
Beyond the preview
Go deeper on NCT04931017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04931017.